Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
Altered expression of microRNA-23a in psoriatic arthritis modulates synovial fibroblast pro-inflammatory mechanisms
Sarah M Wade1, Michelle Trenkmann2, Trudy McGarry1
1Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, University College Dublin, Dublin, Ireland.
Objectives:
To investigate the functional role of miR-23a in synovial fibroblasts (SFC) activation in psoriatic arthritis (PsA).
Methods:
Differential expression of the miR-23a-27a-24-2 cluster was identified by real-time quantitative PCR in PsA synovial tissue and peripheral blood mononuclear cells (PBMC) compared to osteoarthritis (OA) and correlated with disease activity. For regulation experiments, PsA synovial fibroblasts (SFC) were cultured with Toll-like receptor (TLR) ligands and pro-inflammatory cytokines. PsA SFC were transfected with a miR-23a inhibitor to assess the functional effect on migration, invasion and expression of pro-inflammatory meditators. The direct interaction between miR-23a and predicted target mRNA, phosphodiesterase 4B (PDE4B), was examined by luciferase reporter gene assay, with the expression and regulation confirmed by RT-PCR and western blot. A PDE4 inhibitor was used to analyse the function of PDE4B signalling in both miR-23a and Poly(I:C)-induced PsA SFC activation.
Results:
Synovial tissue expression of miR-23a was lower in PsA compared to OA and correlated inversely with disease activity and synovitis. TLR activation via Poly(I:C) and LPS, but not Pam3CSK4, significantly decreased miR-23a expression, with no significant effect observed in reponse to stimulation with pro-inflammatory cytokines. Decreased miR-23a expression enhanced PsA SFC migration, invasion and secretion of IL-6, IL-8, MCP-1, RANTES and VEGF. We identified PDE4B as a direct target of miR-23a and demonstrated enhanced mRNA and protein expression of PDE4B in anti-miR-23a transfected PsA SFC. Poly(I:C) and/or miR-23a-induced migration and enhanced cytokine expression was suppressed by the blockade of PDE4 signalling.
Conclusions:
In PsA, dysregulated miR-23a expression contributes to synovial inflammation through enhanced SFC activation, via PDE4B signalling, and identifies a novel anti-inflammatory mechanism of PDE4 blockade.
Insights
In psoriatic arthritis (PsA), lower miR-23a expression promotes synovial fibroblast activation and inflammation. Blocking PDE4 signaling offers a novel therapeutic approach for PsA by inhibiting this pathway.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Psoriatic arthritis (PsA) involves synovial inflammation driven by fibroblast activation.
- MicroRNAs (miRNAs) play crucial roles in regulating cellular processes, including inflammation.
- The specific role of miR-23a in PsA synovial fibroblast (SFC) activation remains unclear.
Purpose of the Study:
- To investigate the functional role of miR-23a in synovial fibroblast activation in psoriatic arthritis (PsA).
- To elucidate the molecular mechanisms underlying miR-23a's regulation of SFCs in PsA.
- To explore the potential of targeting miR-23a or its downstream pathways for PsA therapy.
Main Methods:
- Real-time quantitative PCR (RT-qPCR) was used to assess miR-23a cluster expression in PsA and osteoarthritis (OA) tissues and peripheral blood mononuclear cells (PBMCs).
- PsA SFCs were stimulated with Toll-like receptor (TLR) ligands and cytokines, and transfected with miR-23a inhibitors to evaluate effects on migration, invasion, and inflammatory mediator secretion.
- Luciferase reporter assays, RT-PCR, and Western blotting were employed to confirm the direct interaction between miR-23a and its target, phosphodiesterase 4B (PDE4B).
- The functional role of PDE4B signaling was assessed using a PDE4 inhibitor in miR-23a and Poly(I:C)-induced PsA SFC activation models.
Main Results:
- miR-23a expression was significantly lower in PsA synovial tissue compared to OA and inversely correlated with disease activity and synovitis.
- TLR activation (Poly(I:C), LPS) decreased miR-23a expression in PsA SFCs, leading to enhanced migration, invasion, and secretion of pro-inflammatory cytokines (IL-6, IL-8, MCP-1, RANTES, VEGF).
- PDE4B was identified as a direct target of miR-23a, with its expression upregulated upon miR-23a inhibition. Blockade of PDE4 signaling attenuated miR-23a and Poly(I:C)-induced SFC activation.
Conclusions:
- Dysregulated miR-23a expression in PsA contributes to synovial inflammation by enhancing SFC activation via PDE4B signaling.
- PDE4B signaling represents a key mediator in miR-23a-driven PsA pathogenesis.
- Targeting PDE4 signaling offers a novel therapeutic strategy for managing psoriatic arthritis by mitigating synovial inflammation.
Related Concept Videos
MicroRNAs
MicroRNAs
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Structural Joints: Synovial Joints
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...

